Screening patterns within organized programs and survival of Italian women with invasive cervical cancer

Preventive Medicine

Volumn 57, Issue 3, 2013, Pages 220-226

  Zucchetto, Antonella ^a,b   Ronco, Guglielmo ^c   Giorgi Rossi, Paolo ^d   Zappa, Marco ^e   Ferretti, Stefano ^f   Franzo, Antonella ^g   Falcini, Fabio ^h   Visioli, Carmen Beatriz ^e   Zanetti, Roberto ^c   Biavati, Patrizia ⁱ   La Rosa, Francesco ^j   Baracco, Susanna ^k   Federico, Massimo ^l   Campari, Cinzia ^d   De Togni, Aldo ^f   Piffer, Silvano ^m   Pannozzo, Fabio ⁿ   Fusco, Mario ^o   Michiara, Maria ^p   Castaing, Marine ^q   Seghini, Pietro ^r   Tisano, Francesco ^s   Serraino, Diego ^a   more..

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Center for Oncologic Prevention   (Italy)

^d Local Health Unit of Reggio Emilia   (Italy)

^e Cancer Prevention and Research Institute ISPO   (Italy)

^f UNIVERSITY OF FERRARA   (Italy)

^g Friuli Venezia Giulia Central Health Direction   (Italy)

^h DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

ⁱ City of Bologna Local Health Trust   (Italy)

^j UNIVERSITY OF PERUGIA   (Italy)

^k VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^l UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^m Unit of Observational Epidemiology   (Italy)

ⁿ Latina Province Cancer Registry   (Italy)

^o Campania Cancer Registry   (Italy)

^p UNIVERSITY HOSPITAL OF PARMA   (Italy)

^q UNIVERSITY OF CATANIA   (Italy)

^r Piacenza Cancer Registry   (Italy)

^s Siracusa Local Health Unit 8   (Italy)

more..

Author keywords

Cervical cancer; Cytology; Organized screening program; Screening history

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; ITALY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SQUAMOUS CELL; SURVIVAL RATE; TUMOR INVASION; UTERINE CERVIX CANCER;

CANCER REGISTRY; CERVICAL CANCER; CI; CONFIDENCE INTERVAL; CR; CYTOLOGY; FIGO; HAZARD RATIO; HR; ICC; ICD; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS; INVASIVE CERVICAL CANCER; NOS; NOT OTHERWISE SPECIFIED; OCSP; ODDS RATIO; OR; ORGANIZED CERVICAL SCREENING PROGRAM; ORGANIZED SCREENING PROGRAM; SCREENING HISTORY; WHO; WORLD HEALTH ORGANIZATION;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; ITALY; MASS SCREENING; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PATIENT ACCEPTANCE OF HEALTH CARE; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 84881609346     PISSN: 00917435     EISSN: 10960260     Source Type: Journal    
DOI: 10.1016/j.ypmed.2013.05.018     Document Type: Article

References (27)

1. Andrae B., Kemetli L., Sparén P., et al. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J. Natl. Cancer Inst. 2008, 100:622-629.
2. Andrae B., Andersson T.M.L., Lambert P.C., et al. Screening and cervical cancer cure: a population based cohort study. Br. Med. J. 2012, 344:e900.
3. Arbyn M., Anttila A., Jordan J., et al. European guidelines for quality assurance in cervical screening 2008, Office for official publications of the European communities, Luxembourg. 2nd edition. G. Ronco, U. Schenck, N. Segnan, H.G. Wiener, H. Herbert, J. Daniel, L. Von Karsa (Eds.).
4. Arbyn M., Rebolj M., De Kok I.M., et al. The challenges of organising cervical screening programmes in the 15 old member states in the European Union. Eur. J. Cancer 2009, 45:2671-2678.
5. Bos A.B., Rebolj M., Habbema J.D.F., van Balleggoijen M. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands. Int. J. Cancer 2006, 119:2372-2375.
6. Bray F., Loos A.H., McCarron P., et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol. Biomarkers Prev. 2005, 14:677-686.
7. Cox D.R. Regression models and life tables. J. R. Stat. Soc. 1972, 34:187-220.
8. Cuzick J., Clavel C., Petry K.U., et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int. J. Cancer 2006, 119:1095-1101.
9. Dillner J., Rebolj M., Birembaut P., et al. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. Br. Med. J. 2008, 337:a1754.
10. Hosmer D.W., Lemeshow S. Applied logistic regression 2000, John Wiley & Sons, New York. Second edition.
11. Ingemann-Hansen O., Lidang M., Niemann I., et al. Screening history of women with cervical cancer: a 6-year study in Aarhus, Denmark. Br. J. Cancer 2008, 98:1292-1294.
12. International Agency for Research on Cancer Cervix cancer screening. IARC handbooks of cancer prevention 2005, vol. 10:1-302. IARC press, Lyon.
13. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 1958, 53:457-481.
14. Kirschner B., Poll S., Rygaard C., Wahlin A., Junge J. Screening history in women with cervical cancer in a Danish population-based screening program. Gynecol. Oncol. 2011, 120:68-72.
15. Lindqvist P.G., Hellsten C., Rippe A. Screening history of women in Malmö with invasive cervical cancer. Eur. J. Obstet. Gynecol. Reprod. Biol. 2008, 137:77-83.
16. Nieminen P., Kallio M., Anttila A., Hakama M. Organised vs. spontaneous pap-smear screening for cervical cancer: a case-control study. Int. J. Cancer 1999, 83:55-58.
17. PASSI (Progressi delle Aziende Sanitarie per la Salute in Italia) Rapporto nazionale Passi 2011: screening cervicale Available at, (last accessed 18/4/2013). http://www.epicentro.iss.it/passi/rapporto2011/ScreeningCervicale.asp.
18. Quinn M., Babb P., Jones J., Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. Br. Med. J. 1999, 318:904-908.
19. Ronco G., Pilutti S., Patriarca S., et al. Turin Cervical Screening Working Group. Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992-98. Br. J. Cancer 2005, 93:376-378.
20. Ronco G., Giubilato P., Naldoni C., et al. Extension of organised cervical screening programmes in Italy and their process indicators: 2010 activity. The National Centre for Screening Monitoring. 10th Report. Epidemiol. Prev. 2012, 36(6, Suppl. 1):39-54.
21. Rothmann K.J., Greenland S., Lash T.L. Modern epidemiology 2008, Lippincott William & Wilkins, Philadelphia. Third edition.
22. Sasieni P., Cuzick J., Lynch-Farmery E., the National co-ordinating network for cervical screening working group Estimating the efficacy of screening by auditing smear histories of women with and without cervical cancer. Br. J. Cancer 1996, 73:1001-1005.
23. Sasieni P., Castanon A., Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. Br. Med. J. 2009, 339:b2968.
24. Solomon D., Davey D., Kurman R., et al. The 2001 Bethesda System. J. Am. Med. Assoc. 2002, 287:2114-2119.
25. Van der Aa M.A., Schutter E.M.J., Looijen-Salamon M., Martens J.E., Siesling S. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001. Eur. J. Obstet. Gynecol. Reprod. Biol. 2008, 139:204-209.
26. Zorzi M., Del Mistro A.R., Farruggio A., et al. Use of high-risk human papillomavirus DNA test as primary test in cervical cancer screening programme: a population-based cohort study. Br. J. Obstet. Gynaec 2013, (in press). 10.1111/1471-0528.12272.
27. Zucchetto A., Franceschi S., Clagnan E., et al. Screening history of women with invasive cervical cancer in north-east Italy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010, 152:200-204.